Skip to main content
. 2023 Sep 27;42(1):26–37. doi: 10.1200/JCO.23.01696

FIG A2.

FIG A2.

Forest plots displaying achievement of MRD negativity end point according to specific subsets of transplant-eligible (A) and transplant-noneligible (B) patients. HRCA, high-risk cytogenic aberration; ISS, International Staging System; LDH, lactate dehydrogenase; MRD, minimal residual disease; R2-ISS, Second Revision of the International Staging System.